Diff Profiles › MTBLS1866_0002_00000001

non_COVID_19_healthy_vs_non_critical_COVID_19

non-COVID-19 healthy vs non-critical COVID-19

p-value ≤ 0.05 6 significant 2025-09-26 00:00:00 Study: MTBLS1866
22 Total Features
6 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS1866_0002_00000001
Linked study
MTBLS1866 — Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
Comparison
non-COVID-19 healthy vs non-critical COVID-19
Group A
Samples from healthy individuals without COVID-19.. Provides a baseline for identifying metabolic changes due to COVID-19.
Group B
Samples from non-critical COVID-19 patients.. Understanding the metabolic profile of non-critical COVID-19 patients helps in identifying potential biomarkers and therapeutic targets.
Total features tested
22
Significant features
6
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
SPJFYYJXNPEZDW-FTJOPAKQSA-N 1-Linoleoylglycerophosphocholine down 0.3307 5.36e-17
TWBVHOYVCUOMJY-PAUXXPOVSA-N LPE 0:0/22:6(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>) up 2.063 1.13e-06
SVRBKLJIDJHADS-USWSLJGRSA-N LPE(18:2) down 0.5184 4.31e-06
ZMHRXVSSWJALGN-GOGKNFEWSA-N LysoPE(0:0/22:5(4Z,7Z,10Z,13Z,16Z)) up 2.011 0.000322
KIHAGWUUUHJRMS-JOCHJYFZSA-N phosphatidylethanolamine zwitterion (18:0) up 1.549 9.92e-06
VLFJNHPNIOTOOA-YMIVKDKMSA-N LysoPE(0:0/22:4(7Z,10Z,13Z,16Z)) up 1.866 0.0127